Stable Istotope Labelled Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Istotope Labelled Abatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade |
|---|---|
| Source | DrugBank DB01281 |
| Species | Human |
| Expression system | Mammalian cells |
| Molecular weight | 92kDa |
| Purity | >95% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue Ice |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Aliases /Synonyms | Abatacept |
| Reference | PX-TA1020-SIL |
| Related Products | PX-P4018 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | hG1-Fc |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
| Formula | C3498H5458N922O1090S32 |
General information about Abatacept
Abatacept est une protéine de fusion composée du domaine extracellulaire de l’antigène 4 cytotoxique humain associé au lymphocyte T (CTLA-4) lié à une partie Fc modifiée d’immunoglobuline humaine (IgG1) qui inhibe le signal de co-stimulation CD80/86 nécessaire à l’activation des lymphocytes T exprimant le CD28. This product is for research use only.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.